Advertisement

Transcatheter Aortic Valve Implantation: Edwards SAPIEN 3

  • Marco Barbanti
  • Martina Patanè
  • Ketty La Spina
Chapter

Abstract

The Edwards SAPIEN 3 (Edwards Lifesciences, Irvine, CA, USA) is the last generation balloon-expandable transcatheter aortic valve, which incorporates features to reduce vascular complications and paravalvular regurgitation (PVR) and to improve precise and easy positioning.

References

  1. 1.
    Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.CrossRefPubMedGoogle Scholar
  2. 2.
    Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–704.CrossRefPubMedGoogle Scholar
  3. 3.
    Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.CrossRefPubMedGoogle Scholar
  4. 4.
    Barbanti M, Capranzano P, Ohno Y, et al. Early discharge after transfemoral transcatheter aortic valve implantation. Heart. 2015;101:1485–90.Google Scholar
  5. 5.
    Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521–643.CrossRefPubMedGoogle Scholar
  6. 6.
    Tamburino C, Barbanti M, D’Errigo P, et al., OBSERVANT Research Group. 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian observant study. J Am Coll Cardiol. 2015;66:804–12.Google Scholar
  7. 7.
    Leon MB, Smith CR, Mack MJ, et al., PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.Google Scholar
  8. 8.
    Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Barbanti M, Binder RK, Freeman M, et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention. 2013;9:929–35.CrossRefPubMedGoogle Scholar
  10. 10.
    Hayashida K, Lefevre T, Chevalier B, et al. Impact of post-procedural aortic regurgitation on mortality after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5:1247–56.CrossRefPubMedGoogle Scholar
  11. 11.
    Kodali S, Pibarot P, Douglas PS, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards SAPIEN valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015;36:449–56.CrossRefPubMedGoogle Scholar
  12. 12.
    Hayashida K, Bouvier E, Lefevre T, et al. Impact of CT-guided valve sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantation. EuroIntervention. 2012;8:546–55.CrossRefPubMedGoogle Scholar
  13. 13.
    Jilaihawi H, Kashif M, Fontana G, et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol. 2012;59:1275–86.CrossRefPubMedGoogle Scholar
  14. 14.
    Willson AB, Webb JG, Labounty TM, et al. 3-Dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol. 2012;59:1287–94.CrossRefPubMedGoogle Scholar
  15. 15.
    Binder RK, Webb JG, Willson AB, et al. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial. J Am Coll Cardiol. 2013;62:431–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Barbanti M, Yang TH, Rodes Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128:244–53.CrossRefPubMedGoogle Scholar
  17. 17.
    Barbanti M, Leipsic J, Binder R, et al. Underexpansion and ad hoc post-dilation in selected patients undergoing balloon-expandable transcatheter aortic valve replacement. J Am Coll Cardiol. 2014;63:976–81.CrossRefPubMedGoogle Scholar
  18. 18.
    Yang TH, Webb JG, Blanke P, et al. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the SAPIEN 3: a comparison with the SAPIEN XT. JACC Cardiovasc Interv. 2015;8:462–71.CrossRefPubMedGoogle Scholar
  19. 19.
    Barbanti M, Sgroi C, Immè S, et al. Usefulness of contrast injection during balloon aortic valvuloplasty before transcatheter aortic valve replacement: a pilot study. EuroIntervention. 2014:10(2):241–7.Google Scholar
  20. 20.
    Barbanti M, Buccheri S, Rodés-Cabau J, et al. Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis. Int J Cardiol. 2017;245:83–9.Google Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Marco Barbanti
    • 1
  • Martina Patanè
    • 2
  • Ketty La Spina
    • 1
  1. 1.Ferrarotto Hospital, University of CataniaCataniaItaly
  2. 2.Centro Cuore MorgagniPedara (CT)Italy

Personalised recommendations